Scabies is a skin condition caused by mites that get under your skin, causing you to itch. It’s extremely contagious and can ...

Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & ...

“While long hot showers feel oh so good in the winter, hot water strips moisture from our skin as well, further exacerbating ...

Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

Adults with atopic eczema are significantly more likely to experience suicidal thoughts than those without the skin condition ...

Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...

An NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled.

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...

Vixarelimab showed significant symptom relief and disease progression reduction in prurigo nodularis compared with placebo across all doses. A phase 2b trial found vixarelimab rapidly reduced itch and ...

A rash that doesn't heal may be a sign of cancer. Basal cell carcinoma is the most common type of skin cancer. Petechiae can resemble rashes but don't typically itch. A rash that doesn’t heal or go ...